Anebulo Pharmaceuticals, Inc. Reports Q4 Loss of $2.14 Million
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 29 2025
0mins
Source: NASDAQ.COM
Company Financial Performance: Anebulo Pharmaceuticals, Inc. reported a loss of $2.14 million for the fourth quarter, compared to a loss of $1.35 million in the same period last year.
Earnings Per Share: The earnings per share (EPS) remained unchanged at -$0.05 for both this year and last year.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
